Role of heart and its diseases in the etiology of depression according to Avicenna’s point of view and its comparison with views of classic medicine

International Journal of Preventive Medicine

Volumn 2015-June, Issue , 2015, Pages

  Yousofpour, Mohammad ^a   Kamalinejad, Mohammad ^b   Esfahani, Mohammad Mahdi ^c,d   Shams, Jamal ^b   Tehrani, Hassan Hoshdar ^b   Bahrami, Mohsen ^d  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Department of Iranian Traditional Medicine School of Iranian Traditional Medicine Research Center of Quran Hadith and Medicine   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Avicenna; Cardiovascular diseases; Depression; Heart diseases; Treatment

Indexed keywords

BETA THROMBOGLOBULIN; INTERLEUKIN 1; INTERLEUKIN 6; THROMBOCYTE FACTOR 4; TUMOR NECROSIS FACTOR;

CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DSM-IV-TR; EMOTIONALITY; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART RATE VARIABILITY; HUMAN; INFERIOR CAVA VEIN; MAJOR DEPRESSION; MEDICAL EXPERT; MELANCHOLIA; MORBIDITY; MORTALITY; PATHOGENESIS; PROGNOSIS; PROTEIN BLOOD LEVEL; PULSE RATE; REVIEW; SYSTEMATIC REVIEW; TEMPERAMENT;

EID: 84930917858     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: 10.4103/2008-7802.158178     Document Type: Review

References (62)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-42.
2. Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom’s General Practice Research Database. Arch Gen Psychiatry 2007;64:242-9.
3. Almeida OP, Alfonso H, Yeap BB, Hankey GJ, Flicker L. Cardiovascular diseases do not influence the mental health outcome of older men with depression over 6 years. J Affect Disord 2013;144:248-52.
4. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 2002;23:51-61.
5. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, et al. Depression and cardiac mortality: Results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221-7.
6. Polsky D, Doshi JA, Marcus S, Oslin D, Rothbard A, Thomas N, et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med 2005;165:1260-6.
7. Jiang W, Hasselblad V, Krishnan RR, O’Connor CM. Patients with CHF and depression have greater risk of mortality and morbidity than patients without depression. J Am Coll Cardiol 2002;39:919-21.
8. Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996;78:613-7.
9. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996;94:3123-9.
10. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, et al. Depression and coronary heart disease: Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation 2008;118:1768-75.
11. Freedland KE, Rich MW, Skala JA, Carney RM, Dávila-Román VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003;65:119-28.
12. Ladwig KH, Kieser M, König J, Breithardt G, Borggrefe M. Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. Eur Heart J 1991;12:959-64.
13. Frasure-Smith N, Lespérance F. Depression and cardiac risk: Present status and future directions. Postgrad Med J 2010;86:193-6.
14. Lespérance F, Frasure-Smith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000;160:1354-60.
15. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. J Am Med Assoc 1993;270:1819-25.
16. Blumenthal JA, Lett HS, Babyak MA, White W, Smith PK, Mark DB, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003;362:604-9.
17. Sullivan MD, LaCroix AZ, Spertus JA, Hecht J, Russo J. Depression predicts revascularization procedures for 5 years after coronary angiography. Psychosom Med 2003;65:229-36.
18. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001;161:1849-56.
19. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003;65:201-10.
20. World Health Organization. Traditional Medicine Strategy. Geneva: WHO; 2002-2005. p. 7-43.
21. Braunwald E, Bonow RO. Cardiovascular Medicine. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia: Elsevier Saunders; 2012. p. 1042-7.
22. Elgood C. Iranian Medical History and Lands of the Eastern Caliphate. Tehran: Amir Kabir; 1991. p. 22-37.
23. Shoja MM, Tubbs RS, Loukas M, Khalili M, Alakbarli F, Cohen-Gadol AA. Vasovagal syncope in the Canon of Avicenna: The first mention of carotid artery hypersensitivity. Int J Cardiol 2009;134:297-301.
24. Vickers A. Recent advances: Complementary medicine. BMJ 2000;321:683-6.
25. Najmabadi M. History of Medicine in Iran. Tehran: Tehran University Publication; 1992. p. 81.
26. Avicenna H. Al-Qanon fi al-Tibb (Canon on Medicine). Vol. 2. Beirut, Lebanon: Alaalami Library Publication; 2005. p. 9, 11, 36, 41-9, 113,196-7, 294-5.
27. Pozuelo L, Tesar G, Zhang J, Penn M, Franco K, Jiang W. Depression and heart disease: What do we know, and where are we headed? Cleve Clin J Med 2009;76:59-70.
28. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: Systematic review and meta analysis. Int J Geriatr Psychiatry 2007;22:613-26.
29. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:953-62.
30. Carney RM, Freedland KE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 2003;54:241-7.
31. O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, et al. Safety and efficacy of sertraline for depression in patients with heart failure: Results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010;56:692-9.
32. van Melle JP, de Jonge P, Honig A, Schene AH, Kuyper AM, Crijns HJ, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007;190:460-6.
33. Khorasani SM. Moalejate Aghili. Tehran: Tehran University of Medical Science: Institute for Islamic and Complementary Medicine; 2008. p. 578-9.
34. Ismaeil Jorjani SI. Al-Aghraz al-Tibbiyahva al-Mabahes al-Alaiyah. (Medical Goals Allaii’s Discussions). In: Tajbakhsh H, editor. Tehran: Tehran University Publication; 2006. p. 13, 98, 201, 238, 623.
35. Ahvazi A A. Kamil al-Sana’a al-Tibbiyah (Maleky Medicine). Qom: Jalal al-Din. 1st ed. 2008; pp. 2–3,381,413-414.
36. Kermani NIE. Sharhe Asbaab-o-Alaamaat of Samarghandi (Describe the etiology and symptoms). Qom: Jalal al-Din,. 2008; pp. 130,572.
37. Kaplan V, Sadock B. Pocket Handbook of Clinical Psychiatry. Translated by: Arjmand M. 5th ed. Tehran: Arjmand Publication; 2010. p. 210, 215.
38. Dunlop DD, Lyons JS, Manheim LM, Song J, Chang RW. Arthritis and heart disease as risk factors for major depression: The role of functional limitation. Med Care 2004;42:502-11.
39. Kapfhammer HP. The relationship between depression, anxiety and heart disease–A psychosomatic challenge. Psychiatr Danub 2011;23:412-24.
40. Kim YH, Kim SH, Lim SY, Cho GY, Baik IK, Lim HE, et al. Relationship between depression and subclinical left ventricular changes in the general population. Epidemiology 2012;98:1378-83.
41. Wan CF, Li ZH, Xu GJ, Liu SS, Qi XY. Effects of depressive disorder on monocytic expression of CD (40) and plasma IL-8 concentration in senile coronary heart disease patients. Zhonghua Yi Xue Za Zhi 2011;91:2459-63.
42. Kemp DE, Malhotra S, Franco KN, Tesar G, Bronson DL. Heart disease and depression: Don’t ignore the relationship. Cleve Clin J Med 2003;70:745-6, 749.
43. Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, Barbour KA, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 2007;69:587-96.
44. Carney RM, Blumenthal JA, Freedland KE, Youngblood M, Veith RC, Burg MM, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004;66:466-74.
45. Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007;297:367-79.
46. Zipfel S, Schneider A, Wild B, Löwe B, Jünger J, Haass M, et al. Effect of depressive symptoms on survival after heart transplantation. Psychosom Med 2002;64:740-7.
47. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev 2011;9:CD008012.
48. van Ravenswaaij-Arts CM, Kollée LA, Hopman JC, Stoelinga GB, van Geijn HP. Heart rate variability. Ann Intern Med 1993;118:436-47.
49. Otte C, Neylan TC, Pipkin SS, Browner WS, Whooley MA. Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: Findings from the Heart and Soul Study. Am J Psychiatry 2005;162:2139-45.
50. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001;104:2024-8.
51. Carney RM, Blumenthal JA, Freedland KE, Stein PK, Howells WB, Berkman LF, et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005;165:1486-91.
52. de Jonge P, Mangano D, Whooley MA. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: Findings from the Heart and Soul Study. Psychosom Med 2007;69:735-9.
53. Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997;42:290-5.
54. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313-7.
55. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
56. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005;111:2299-305.
57. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002;90:1279-83.
58. Kramer P. Against Depression. New York: Viking Press; 2005. p. 184.
59. Schwartz GE, Weinberger DA, Singer JA. Cardiovascular differentiation of happiness, sadness, anger, and fear following imagery and exercise. Psychosom Med 1981;43:343-64.
60. Shimbo D, Chaplin W, Kuruvilla S, Wasson LT, Abraham D, Burg MM. Hostility and platelet reactivity in individuals without a history of cardiovascular disease events. Psychosom Med 2009;71:741-7.
61. Bagherian R, Gilani B, Bahrami Ehsan H, Sanei H. Relationship between depressions of post MI. and functional of left ventricular. Iran J Clin Psychiatry Psychol 2008;4:420-7.
62. van Melle JP, de Jonge P, Kuyper AM, Honig A, Schene AH, Crigns H, et al. Prediction of depressive disorder following myocardial infarction: Data from the Myocardial Infarction and Depression–Intervention Trial (MINDIT). Int J Cardiol 2005;109:88-94.